Source:http://linkedlifedata.com/resource/pubmed/id/19250113
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2009-3-2
|
pubmed:abstractText |
Left ventricular (LV) postero-lateral scar and total scar burden are factors responsible for a poor response to cardiac resynchronization therapy (CRT). Contrast-enhanced magnetic resonance imaging (CMR) and (99m)Tc-2-methoxy isobutyl isonitrile single photon emission computed tomography (SPECT) perfusion imaging are widely used to detect myocardial scar tissue; however, their ability to detect regional scars and predict a positive response to CRT has not been fully evaluated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1540-8159
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
32 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S57-62
|
pubmed:meshHeading |
pubmed-meshheading:19250113-Aged,
pubmed-meshheading:19250113-Cardiac Pacing, Artificial,
pubmed-meshheading:19250113-Cardiomyopathy, Dilated,
pubmed-meshheading:19250113-Cicatrix,
pubmed-meshheading:19250113-Female,
pubmed-meshheading:19250113-Humans,
pubmed-meshheading:19250113-Magnetic Resonance Imaging,
pubmed-meshheading:19250113-Male,
pubmed-meshheading:19250113-Myocardial Stunning,
pubmed-meshheading:19250113-Reproducibility of Results,
pubmed-meshheading:19250113-Sensitivity and Specificity,
pubmed-meshheading:19250113-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:19250113-Treatment Failure,
pubmed-meshheading:19250113-Ventricular Dysfunction, Left
|
pubmed:year |
2009
|
pubmed:articleTitle |
Magnetic resonance imaging is superior to cardiac scintigraphy to identify nonresponders to cardiac resynchronization therapy.
|
pubmed:affiliation |
Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|